CONCERT PHARMACEUTICALS INC's ticker is and the CUSIP is 206022905. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $65,992 | -41.6% | 11,300 | -33.1% | 0.00% | – |
Q3 2022 | $113,000 | +121.6% | 16,900 | +39.7% | 0.00% | – |
Q2 2022 | $51,000 | +1600.0% | 12,100 | +1110.0% | 0.00% | – |
Q1 2022 | $3,000 | -50.0% | 1,000 | -50.0% | 0.00% | – |
Q4 2021 | $6,000 | -80.6% | 2,000 | -79.2% | 0.00% | – |
Q3 2021 | $31,000 | -45.6% | 9,600 | -29.4% | 0.00% | – |
Q2 2021 | $57,000 | -68.3% | 13,600 | -62.2% | 0.00% | – |
Q1 2021 | $180,000 | +542.9% | 36,000 | +1536.4% | 0.00% | – |
Q4 2020 | $28,000 | +366.7% | 2,200 | +266.7% | 0.00% | – |
Q3 2020 | $6,000 | -45.5% | 600 | -45.5% | 0.00% | – |
Q2 2020 | $11,000 | -35.3% | 1,100 | -42.1% | 0.00% | – |
Q1 2020 | $17,000 | -65.3% | 1,900 | -64.2% | 0.00% | – |
Q4 2019 | $49,000 | +2350.0% | 5,300 | +1666.7% | 0.00% | – |
Q3 2019 | $2,000 | -93.5% | 300 | -88.5% | 0.00% | – |
Q1 2019 | $31,000 | -82.4% | 2,600 | -81.4% | 0.00% | -100.0% |
Q4 2018 | $176,000 | +5766.7% | 14,000 | +6900.0% | 0.00% | – |
Q3 2018 | $3,000 | -97.7% | 200 | -97.4% | 0.00% | -100.0% |
Q2 2018 | $131,000 | +47.2% | 7,800 | +100.0% | 0.00% | 0.0% |
Q1 2018 | $89,000 | -91.0% | 3,900 | -89.8% | 0.00% | -85.7% |
Q4 2017 | $993,000 | +681.9% | 38,400 | +346.5% | 0.01% | +600.0% |
Q3 2017 | $127,000 | +15.5% | 8,600 | +8.9% | 0.00% | 0.0% |
Q2 2017 | $110,000 | -57.0% | 7,900 | -47.3% | 0.00% | -66.7% |
Q1 2017 | $256,000 | +1405.9% | 15,000 | +900.0% | 0.00% | – |
Q2 2016 | $17,000 | -5.6% | 1,500 | +15.4% | 0.00% | – |
Q1 2016 | $18,000 | +800.0% | 1,300 | +1200.0% | 0.00% | – |
Q4 2015 | $2,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |